Aptamers as Diagnostic Tools in Cancer
Cancer is the second leading cause of death worldwide. Researchers have been working hard on investigating not only improved therapeutics but also on early detection methods, both critical to increasing treatment efficacy, and developing methods for disease prevention. The use of nucleic acids, or a...
Main Authors: | Dario Ruiz Ciancio, Mauricio R. Vargas, William H. Thiel, Martin A. Bruno, Paloma H. Giangrande, María Belén Mestre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/11/3/86 |
Similar Items
-
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
by: Prabir Kumar Kulabhusan, et al.
Published: (2020-07-01) -
Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims
by: Arash Mohammadinejad, et al.
Published: (2024-01-01) -
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
by: Sven Kruspe, et al.
Published: (2017-08-01) -
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics
by: Domenica Musumeci, et al.
Published: (2017-12-01) -
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses
by: Víctor M. González, et al.
Published: (2016-12-01)